Literature DB >> 29104129

Classifying Fecal Microbiota Transplantation Failure: An Observational Study Examining Timing and Characteristics of Fecal Microbiota Transplantation Failures.

Jessica R Allegretti1, Andrew S Allegretti2, Emmalee Phelps3, Huiping Xu4, Monika Fischer3, Zain Kassam5.   

Abstract

Fecal microbiota transplantation (FMT) is an effective treatment for recurrent Clostridium difficile infection (rCDI), with cure rates higher than 80%.1-3 FMT failure is defined as diarrhea and a positive stool laboratory test for C difficile at any point during the 8-week follow-up period after FMT.4.
Copyright © 2018 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2017        PMID： 29104129     DOI： 10.1016/j.cgh.2017.10.031

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


  7 in total

1.  Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in Patients With Multiple Comorbidities: Long-Term Safety and Efficacy Results From a Tertiary Care Community Hospital.

Authors:  Charumathi Raghu Subramanian; Swapna Talluri; Safi Ullah Khan; Jeffry A Katz; Michael Georgetson; Preetika Sinh
Journal:  Gastroenterology Res       Date:  2020-08-14

2.  Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience.

Authors:  Yao-Wen Cheng; Emmalee Phelps; Vincent Ganapini; Noor Khan; Fangqian Ouyang; Huiping Xu; Sahil Khanna; Raseen Tariq; Rachel J Friedman-Moraco; Michael H Woodworth; Tanvi Dhere; Colleen S Kraft; Dina Kao; Justin Smith; Lien Le; Najwa El-Nachef; Nirmal Kaur; Sree Kowsika; Adam Ehrlich; Michael Smith; Nasia Safdar; Elizabeth Ann Misch; Jessica R Allegretti; Ann Flynn; Zain Kassam; Asif Sharfuddin; Raj Vuppalanchi; Monika Fischer
Journal:  Am J Transplant       Date:  2018-08-31       Impact factor: 8.086

Review 3.  Faecal microbiota transplantation for Clostridioides difficile: mechanisms and pharmacology.

Authors:  Alexander Khoruts; Christopher Staley; Michael J Sadowsky
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-08-25       Impact factor: 46.802

4.  Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic.

Authors:  Gianluca Ianiro; Benjamin H Mullish; Colleen R Kelly; Zain Kassam; Ed J Kuijper; Siew C Ng; Tariq H Iqbal; Jessica R Allegretti; Stefano Bibbò; Harry Sokol; Faming Zhang; Monika Fischer; Samuel Paul Costello; Josbert J Keller; Luca Masucci; Joffrey van Prehn; Gianluca Quaranta; Mohammed Nabil Quraishi; Jonathan Segal; Dina Kao; Reetta Satokari; Maurizio Sanguinetti; Herbert Tilg; Antonio Gasbarrini; Giovanni Cammarota
Journal:  Gut       Date:  2020-07-03       Impact factor: 23.059

5.  Development of a rational framework for the therapeutic efficacy of fecal microbiota transplantation for calf diarrhea treatment.

Authors:  Jahidul Islam; Masae Tanimizu; Yu Shimizu; Yoshiaki Goto; Natsuki Ohtani; Kentaro Sugiyama; Eriko Tatezaki; Masumi Sato; Eiji Makino; Toru Shimada; Chise Ueda; Ayumi Matsuo; Yoshihisa Suyama; Yoshifumi Sakai; Mutsumi Furukawa; Katsuki Usami; Hiroshi Yoneyama; Hisashi Aso; Hidekazu Tanaka; Tomonori Nochi
Journal:  Microbiome       Date:  2022-02-21       Impact factor: 14.650

6.  Fecal Microbiota Transplantation Donor and Dietary Fiber Intervention Collectively Contribute to Gut Health in a Mouse Model.

Authors:  Yifan Zhong; Jiahong Cao; Yanfei Ma; Yu Zhang; Jianxin Liu; Haifeng Wang
Journal:  Front Immunol       Date:  2022-02-03       Impact factor: 7.561

7.  Fecal Microbiota Transplantation for Severe or Fulminant Clostridioides difficile Infection: Systematic Review and Meta-analysis.

Authors:  Yi Nong Song; David Yi Yang; Sander Veldhuyzen van Zanten; Karen Wong; Eric McArthur; Claire Zhao Song; Gianluca Ianiro; Giovanni Cammarota; Colleen Kelly; Monika Fischer; Lindsey Russell; Dina Kao
Journal:  J Can Assoc Gastroenterol       Date:  2021-07-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.